Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-02-01
著者
-
Basu Partha
Chittaranjan National Cancer Institute Department Of Gynaecologic Oncology
-
DATTA Sanjoy
GlaxoSmithKline Biologicals
-
BHATLA Neerja
All India Institute of Medical Sciences
-
SURI Vanita
Postgraduate Institute of Medical Education and Research
-
SHASTRI Surendra
Tata Memorial Cancer Hospital
-
BI Dan
GlaxoSmithKline Biologicals
-
DESCAMPS Dominique
GlaxoSmithKline Biologicals
-
BOCK Hans
GlaxoSmithKline Biologicals
-
DAS Amit
Chittarnajan National Cancer Institute
-
GULATI Arti
All India Institute of Medical Sciences
-
JOSEPH Elizabeth
All India Institute of Medical Sciences
-
LAL Neena
All India Institute of Medical Sciences
-
MANDAL Ranajit
Chittaranjan National Cancer Institute
-
NIJHAWAN Raje
Post Graduate Institute of Medical Education and Research
-
PIMPLE Sharmila
Tata Memorial Hospital
関連論文
- HPV vaccination in women over 25 years of age : Asian Cervical Cancer Prevention Advisory Board recommendations
- Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women